Todd Asset Management LLC cut its position in Icon Plc (NASDAQ:ICLR) by 0.4% in the third quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 273,893 shares of the medical research company’s stock after selling 1,168 shares during the quarter. Todd Asset Management LLC owned approximately 0.51% of Icon Plc worth $31,192,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently made changes to their positions in ICLR. New York State Common Retirement Fund increased its holdings in shares of Icon Plc by 0.5% during the third quarter. New York State Common Retirement Fund now owns 445,200 shares of the medical research company’s stock valued at $50,699,000 after acquiring an additional 2,402 shares in the last quarter. Principal Financial Group Inc. increased its holdings in shares of Icon Plc by 71.5% during the third quarter. Principal Financial Group Inc. now owns 768,471 shares of the medical research company’s stock valued at $87,513,000 after acquiring an additional 320,356 shares in the last quarter. Pettee Investors Inc. acquired a new position in shares of Icon Plc during the third quarter valued at about $1,057,000. Tygh Capital Management Inc. increased its holdings in shares of Icon Plc by 78.0% during the third quarter. Tygh Capital Management Inc. now owns 85,006 shares of the medical research company’s stock valued at $9,680,000 after acquiring an additional 37,240 shares in the last quarter. Finally, USA Financial Portformulas Corp acquired a new position in shares of Icon Plc during the third quarter valued at about $278,000. Institutional investors and hedge funds own 91.59% of the company’s stock.

ICLR has been the topic of several recent analyst reports. SunTrust Banks, Inc. upgraded shares of Icon Plc from a “hold” rating to a “buy” rating and upped their price objective for the company from $93.00 to $126.00 in a report on Monday, July 31st. Jefferies Group LLC restated a “buy” rating on shares of Icon Plc in a report on Sunday, July 30th. Credit Suisse Group restated a “buy” rating on shares of Icon Plc in a report on Friday, July 28th. Zacks Investment Research upgraded shares of Icon Plc from a “hold” rating to a “buy” rating and set a $120.00 price objective on the stock in a report on Thursday, August 24th. Finally, ValuEngine upgraded shares of Icon Plc from a “hold” rating to a “buy” rating in a report on Friday, September 1st. Four investment analysts have rated the stock with a hold rating, seven have given a buy rating and two have assigned a strong buy rating to the company’s stock. The stock currently has a consensus rating of “Buy” and an average price target of $121.00.

TRADEMARK VIOLATION WARNING: “Todd Asset Management LLC Sells 1,168 Shares of Icon Plc (ICLR)” was published by Watch List News and is owned by of Watch List News. If you are accessing this piece on another site, it was illegally copied and republished in violation of U.S. and international trademark & copyright legislation. The correct version of this piece can be read at https://www.watchlistnews.com/todd-asset-management-llc-sells-1168-shares-of-icon-plc-iclr/1700748.html.

Shares of Icon Plc (NASDAQ ICLR) traded down $1.55 on Monday, hitting $113.81. The company’s stock had a trading volume of 419,300 shares, compared to its average volume of 368,810. Icon Plc has a twelve month low of $73.76 and a twelve month high of $124.48. The firm has a market cap of $6,163.04, a P/E ratio of 21.84, a PEG ratio of 1.76 and a beta of 0.56. The company has a quick ratio of 1.90, a current ratio of 1.90 and a debt-to-equity ratio of 0.31.

Icon Plc (NASDAQ:ICLR) last issued its earnings results on Thursday, October 26th. The medical research company reported $1.35 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.32 by $0.03. Icon Plc had a return on equity of 28.42% and a net margin of 16.37%. The business had revenue of $440.30 million during the quarter, compared to the consensus estimate of $438.09 million. During the same period last year, the company earned $1.19 EPS. The company’s revenue for the quarter was up 4.8% on a year-over-year basis. equities analysts expect that Icon Plc will post 5.36 EPS for the current year.

Icon Plc Company Profile

ICON public limited company is a contract research organization (CRO), which is engaged in providing outsourced development services to the pharmaceutical, biotechnology and medical device industries. The Company is engaged in the strategic development, management and analysis of programs that support the various stages of the clinical development process, from compound selection to Phase I-IV clinical studies.

Want to see what other hedge funds are holding ICLR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Icon Plc (NASDAQ:ICLR).

Institutional Ownership by Quarter for Icon Plc (NASDAQ:ICLR)

Receive News & Ratings for Icon Plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Icon Plc and related companies with Analyst Ratings Network's FREE daily email newsletter.